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PI3Kδ promotes CD4+ T-cell interactions with
antigen-presenting cells by increasing LFA-1 binding
to ICAM-1
Fabien Garçon and Klaus Okkenhaug
Activation of T lymphocytes by peptide/major histocompatibility complex on antigen-presenting cells (APCs) involves dynamic
contacts between the two cells, during which T cells undergo marked morphological changes. These interactions are facilitated
by integrins. Activation of the T cells increases the binding of the integrin lymphocyte function-associated antigen 1 (LFA-1)
expressed by T cells to intercellular adhesion molecule (ICAM)-1 and ICAM-2 expressed by APCs. The signalling pathways that
control integrin affinities are incompletely defined. The phosphoinositide 3-kinases (PI3Ks) generate second-messenger signalling
molecules that control cell growth, proliferation, differentiation and trafficking. Here we show that in T cells, PI3Kδ attenuates
the activation of Rac1, but sustains the activation of Rap1. Consequently, PI3Kδ increases LFA-1-dependent adhesion to form
stable conjugates with APCs. Increased Rap1 activity and LFA-1 adhesion were only in part mediated by the downstream kinase
Akt, suggesting the involvement of additional phosphatidylinositol(3,4,5)P3-binding proteins. These results establish a link
between PI3K activity, cytoskeletal changes and integrin binding and help explain the impaired T-cell-dependent immune
responses in PI3Kδ-deficient mice.
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Phosphoinositide 3-kinases (PI3Ks) catalyse the conversion of
phosphatidylinositol(4,5)P2 to phosphatidylinositol(3,4,5)P3 (PIP3).
PIP3 acts as a lipid second messenger by recruiting PH domain
containing proteins to the plasma membrane where they activate
signalling pathways that promote proliferation, differentiation, survival
and chemotaxis.1–3 The best understood PIP3 effector is the serine/
threonine kinase Akt, which inactivates Foxo transcription proteins,
whereas increases mechanistic target of rapamycin kinase activity.4,5
These pathways are evolutionary conserved and are thought to be
responsible for many of the biological functions of PI3Ks. However, it
has been estimated that there are up to 50 additional PIP3-binding
proteins in the human genome and the function of many of these
remain to be fully appreciated.6 These include numerous guanine
exchange factors (GEFs) and GTPase-activating proteins (GAPs) that
positively and negatively regulate small GTPases.7
Four class I PI3Ks are expressed in mammalian cells. Each consists
of a constitutive heterodimer between a p110 catalytic subunit and one
of several regulatory subunits. P110α, p110β and p110δ bind to p85α,
p55α, 50α, p85β or p55γ (collectively known as p85) to form PI3Kα,
PI3Kβ or PI3Kδ, respectively. The p85 regulatory subunits contain
SH2 domains that link the p110 subunit to activation by tyrosine
kinases. P110γ by contrast binds to a p84 or p101 regulatory subunit
and these regulatory subunits are bound by Gβγ subunits released
upon engagement of G-protein coupled receptors. We and others have
previously demonstrated key roles for PI3Kδ in T cells using
kinase-dead p110δD910A mice, p110δ− /− knockout mice or the small
molecule inhibitor IC87114.2,8,9 Inhibition of PI3Kδ in T cells results
in a reduction of antigen-induced PIP3 accumulation at the
immunological synapse; reduced T-cell proliferation; failure of naive
T cells to develop into Th1, Th2, Th17 or Tfh subsets;
and production of effector cytokines.10–14 PI3Kδ is also required for
the expression of certain adhesion and chemokine receptors and in
antigen-dependent trafficking of T cells.15–17
Although p110δD910A T cells showed impaired proliferation when
stimulated by peptide antigens in vitro, rigorous proliferation of
p110δD910A T cells was achieved using plastic beads coated with
high-affinity agonist antibodies.10,11,18 Similarly, wortmannin blocked
antigen stimulated, but not anti-CD3-stimulated T-cell functions.19
Because the interactions between T cells and antigen-presenting cells
(APC) involve lower affinity interactions than those provided by
antibodies bound to beads, we reasoned that PI3Kδ may contribute to
increase the stability of the T-cell-APC interaction. Indeed, while
monitoring PIP3 accumulation at the immune synapse in a previous
study we noticed that p110δD910A and IC87114-treated WT T cells
appeared more rounded and tended not to ‘embrace’ the APCs as
effusively as untreated wild-type (WT) cells did.12
T-cell adhesion to APCs is initially mediated by the interaction of
T-cell integrins with their ligands expressed on the surface of the APC.
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Key among the integrins required for the maintenance of the
T cell-APC contact is the αLβ2-integrin lymphocyte function-
associated antigen 1 (LFA-1) that binds to intercellular adhesion
molecule 1 (ICAM)-1 and ICAM-2.20,21 LFA-1 is maintained in a
low-affinity conformation on resting T cells, but T-cell receptor (TCR)
engagement induces its activation and clustering, which increases
adhesion between the T cell and the APC. The importance of these
interactions has been highlighted by the finding that deficiency in either
LFA-1 or ICAM-1 leads to impaired conjugate formation, reduced
responsiveness to antigen, impaired T-cell differentiation and memory
T-cell formation.22–25 Rap1 is a small GTPase and a key regulator of
LFA-1. Transgenic mice expressing an activating mutant of Rap1A
isoform show enhanced adhesion and consequently are hypersensitive
to activation.26 Therefore, there are similarities between the conse-
quences of modulating LFA-1 activity and PI3K activity in T cells.
Here we show that PI3Kδ activity is required to sustain Rap1
activity after stimulation through the TCR. Consistent with this
finding, PI3Kδ is required to increase LFA-1 binding to its ligand
ICAM-1 by mechanisms that are partially dependent on Akt and Rap1.
In addition, we present evidence for dysregulation of the small GTPase
Rac1 and the actin-modifying enzymes cofilin and ERM (ezrin, radixin
and moesin). We propose that PI3Kδ coordinates the regulation of
cytoskeletal and integrin affinity to establish the formation of stable
conjugates between T cells and APCs, which is initiated by low-affinity
antigen-dependent interactions.
RESULTS
PI3Kδ differentially regulates small G proteins
To investigate the role of PI3Kδ in regulating small GTPase activity,
we stimulated WT or p110δD910A T cells with anti-CD3 and
monitored the GTP-bound forms of Rac1, RhoA, Cdc42 and Rap1.
RhoA and Cdc42 activity did not change substantially (Supplementary
Figures 1a, b), whereas Rac activation occurred rapidly after
stimulation with anti-CD3 (Figure 1a). Contrary to our expectations,
Rac1 showed a tendency to be more strongly activated and this activity
was maintained longer in p110δD910A T cells than in WT T
cells (Figure 1a). Acute inhibition of PI3K by using either the
PI3Kδ-specific inhibitor CAL-101 or a pan-PI3K inhibitor
(ZSTK-474) led to enhanced basal Rac1 activity and CAL-101-
treated samples, similar to the p110δD910A mutation, maintained
higher Rac activity (Figure 1b). By contrast, the activation of Rap1
was attenuated in p110δD910A T cells relative to WT T cells,
particularly at later time points (Figure 1c). Thus, sustained Rap1
activation requires PI3Kδ activity.
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Figure 1 p110δ regulates small GTPases activity in CD4+ T cells. The active form of Rac1 (a,b) and Rap1 (c) was purified by GST pull-downs from T cell
lysates after stimulation with an anti-CD3 mAb for the indicated times. For quantification, the relative amount of Rac1-GTP or Rap1-GTP was normalised
according to the total amount of the respective protein. The data are reported as the fold intensity of the normalised GTP-bound protein observed at t=0 in
the WT (a, c) or DMSO (b) condition. P-values were calculated using a two-way repeated-measures ANOVA. *Po0.05. Data presented are representative of at
least three independent experiments.
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Reduced cofilin inactivation and morphological changes in
PIK3δ-deficient T cells
Cofilin is an actin-binding protein important for actin reorganisation.
In resting, T-cell cofilin is maintained inactive by phosphorylation
on Serine 3 by serine/threonine kinases LIMK1.27 LIMK1 is
activated through Rac small GTPase and its effector PAK. Cofilin is
dephosphorylated and activated by Slingshot phosphatases in a
PI3K-dependent manner.28 Immunoblot analysis with an antibody
specific for P-Serine 3 showed that activation of WT T cells decreased
phosphorylation of cofilin in a time-dependent manner (Figure 2a).
By contrast, p110δD910A T cells had higher basal level of cofilin
phosphorylation, which was incompletely dephosphorylated upon
T-cell stimulation (Figure 2a). These results are consistent with higher
Rac activity in p110δD910A, which may lead to increased LIMK activity,
shifting the balance towards more phosphorylation of cofilin.
We also examined the role of p110δ in the phosphorylation of the
ERM proteins that link actin filaments to proteins in the plasma
membrane. The ERM proteins have been shown to be important for
cell deformability and immunological synapse formation and are
also regulated by Rac.29 Similar to cofilin, ERM-dephosphorylation
was less efficiently induced in p110δD910A T cells than in WT T cells
(Figure 2b). These results suggest that PI3Kδ inhibition uncouples the
TCR from key proteins involved in actin cytoskeleton rearrangements,
possibly by altering the flux through the GDP- and GTP- bound states
of Rac.
We next examined the effect of inhibiting PI3Kδ on actin
reorganisation and cell shape changes during T-cell activation. Upon
encountering an antigen-bearing APC, T cells reorganise the actin
cytoskeleton and polarise towards the contact area. In order to follow
this event we transfected OT-II CD4+ T cells with actin-GFP and
allowed them to interact with B cells loaded with OVA323-339 peptide
before imaging them. Pre-treatment of the T cell with a p110δ-specific
inhibitor induced a reduction of the actin-GFP signal at the
contact area (Figure 2c) and quantitative analysis of the intensity
of fluorescence at the contact confirmed that PI3Kδ inhibition
suppressed dynamic actin reorganisation required for productive
interactions with APCs.
PI3Kδ is required for optimal LFA-1-dependent adhesion and
T-cell spreading
The reduced Rap1 activity observed in p110δD910A T cells suggested
that PI3Kδ could be important for LFA-1 binding to ICAM-1. WT
and p110δD910A T cells showed the same level of LFA-1 expression
(Figure 3a). Integrin activation occurs through two distinct mechan-
isms, namely an increase of affinity and/or avidity.20 To examine the
effect of the absence of PI3Kδ activity on LAF-1 affinity and avidity
we used a ligand-complex-based-adhesion-assay.30 In this assay,
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Figure 2 PI3Kδ controls cofilin and ERM regulation and cell polarisation. WT and p110δD910A CD4+ T cells were activated with anti-CD3 and anti-CD28
mAbs for the indicated times and lysed. Lysates were then analysed with the indicated antibodies in order to measure cofilin activity (a) or ERM
phosphorylation (b). For quantification, relative amounts of phospho-cofilin or phospho-ERM were normalised to the total amount of cofilin or ERM. P-values
were calculated using a two-way repeated-measures ANOVA. *Po0.05. Data presented are representative of three independent experiments. (c) Actin-GFP
expressing OT2 CD4+ T cells were pre-treated with DMSO or the p110δ specific inhibitor IC87114 before being incubated with B cells loaded with
OVA323-339 peptide. After 30 min, cells were fixed and the intensity of the fluorescence of actin-GFP at the contact zone measured. Data are representative
of at least three independent experiments.
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p110δD910A T cells showed reduced binding to soluble ICAM-1
clusters upon TCR stimulation (Figures 3b and c). By contrast,
p110δD910A T cells activated with CCL19 showed normal binding to
ICAM-1 (Supplementary Figure 2A), consistent with previous
results.31 Similarly, addition of PMA or Mg increased ICAM-1 binding
to p110δD910A T cells (Supplementary Figure 2B). These results
demonstrate that LFA-1 can be activated by other pathways in
p110δD910A T cells and suggest a specific role for PI3Kδ in linking
the TCR to LFA-1 activation. LFA-1 binding was further analysed by
measuring the ability of cells to bind monomeric ICAM-1. As with
clustered ICAM-1, p110δD910A T cells failed to bind to monomeric
ICAM-1 (Figure 3d). A similar result was obtained by treating WT
T cells with the PI3Kδ-specific inhibitor CAL-101 before measuring
binding to monomeric ICAM-1 (Supplementary Figure 2c). However,
analysis by confocal microscopy revealed that LFA-1 capped normally
in activated p110δD910A T cells, except at the highest concentration of
anti-CD3 (Figure 3e). These results therefore suggest that PI3Kδ
regulates LFA-1 primarily by increasing its affinity for ICAM-1,
although we cannot exclude a role for PI3Kδ in regulating LFA-1
microclusters.
In order to form and maintain a viable cell–cell contact with their
APCs, T cells need to spread and extend membrane tethers to
maximise the contact area with the APC. To mimic this effect,
we measured the spreading of T cells that had been deposited on
coverslips coated with ICAM-1 alone or ICAM-1 and anti-CD3. T-cell
spreading was enhanced by the presence of anti-CD3 as indicated
by their increased measured contact area (Figure 4a). However,
p110δD910A T cells spread less extensively than WT T cells
(Figure 4a). Next, OT2 TCR-transgenic CD4+ T cells were
incubated with APC-presenting OVA323-339 peptide and T cells
making cell–cell contacts were analysed. We found that p110δD910A
T cells polarised less extensively when they interacted with APCs
(Figure 4b).
As Akt is one of the main effectors of PI3K we wanted to assess its
contribution to PI3Kδ-dependent inside–out signal to LFA-1. T cells
treated with an inhibitor of Akt showed reduced activation of Rap1
upon TCR engagement (Figure 5a). This was accompanied by a
reduced binding of LFA-1 to ICAM-1 (Figure 5b). However, this
reduction was not as strong as the one observed when T cells were
treated with the PI3Kδ inhibitor IC87114 or the pan-PI3K inhibitor
ZSTK-474 (Figure 5b), suggesting that another PI3Kδ-dependent
pathway is also involved. We also asked whether we could restore
binding to ICAM-1 by transducing cells with an activated form or
Rap1 (Rap1V12) in p110δD910A T cells. We observed a partial rescue of
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the binding of LFA-1 to ICAM-1 in cells expressing Rap1V12
(Figure 5c). However the binding enhancement never reached the
level observed for WT T cells or p110δD910A T cells transduced with
WT p110δ cDNA (Figure 5c). This suggests that Rap1-independent
pathways can also contribute to LFA-1 activation downstream of
PI3Kδ in T cells.
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T cell-APC cell conjugates formed by p110δD910A CD4+ T cells are
unstable
Within lymph nodes, T cells move about at relatively high rates until
they interact with APCs presenting cognate peptide antigens, which
causes them to arrest, thus enabling the establishment of further
contacts between the T cell and the APC.32,33 To measure the ability of
the TCR to send a signal to arrest p110δD910A T cells, we plated T cells
on ICAM-coated slides as previously described.34 In the absence of
stimulation, p110δD910A T cells migrated at a similar velocity as WT
T cells and stimulation with anti-CD3 reduced the motility of WT and
p110δD910A T cells with similar efficiency (Figure 6a). These results
indicate that the TCR-dependent ‘stop’ signal is intact in p110δD910A
T cells under these conditions. To determine whether PI3Kδ is
required for sustained conjugate formation between T cells and APCs,
we incubated WT or p110δD910A OT2 CD4+ T cells with APCs loaded
with increased concentration of OVA323-339 peptide and counted the
number of conjugates formed. WT OT2 T cells formed stable
conjugates with APCs loaded with OVA323-339 peptide in a dose-
dependent manner (Figure 6b). However, at each peptide concentra-
tion, p110δD910A T cells formed fewer conjugates (Figure 6b). When
WT or p110δD910A OT2 T cells were incubated with APCs not loaded
with peptides, they moved at similar speeds (8.3± 0.87 μmmin− 1 for
WT and 8± 1.2 μmmin− 1 for p110δD910A) suggesting that p110δ was
not involved in the control of the basal motility of the T cells
(Figure 6c). However, when the APCs were presenting OVA323-339
peptide, WT OT2 T cells migrated with a lower mean velocity
(3.2± 0.3 μmmin− 1) and were more likely to reduce their movement
(57.6± 3% moved at o2 μmmin− 1) (Figures 6c and d). By contrast,
p110δD910A T cells retained a significantly higher mean velocity
(5.3± 0.5 μmmin− 1), and were less likely to arrest their movement
(39.8± 4.4%) in presence of peptide antigen. These results suggest that
PI3Kδ contributes to formation of stable interactions between T cells
and APC-presenting cognate peptides antigens.
p110δD910A CD4+ T cells form less-stable T cell-APC interactions in
lymph node slices
Our in vitro results indicated that p110δD910A T cells form less-stable
conjugate using lipopolysaccharide-primed B cells as APCs. In the
lymph node, T cells move in three dimensions along a fibroreticular
network where dendritic cells (DCs) act as the main type of APC
during the initiation of immune responses.35 We therefore investigated
whether the effects of PI3Kδ-deficiency in vitro were also observed
when DCs present peptide antigen within the context of the lymph
node microenvironment. To this end, we prepared agarose-embedded
lymph node slices, which previously have been shown to support
normal lymphocyte motility.36 When added to lymph node
slices together with DCs not presenting OVA323-339 peptide, both
WT and p110δD910A OT2 CD4+ T cells moved at similar mean
velocities (7.9± 0.1 μmmin− 1 and 7.2± 0.2 μmmin− 1, respectively)
(Figure 7a). When the cells were added to a slice together with DCs
presenting OVA323-339 peptide, the WT OT2 T cells moved
at a reduced velocity (5.3± 0.1 μmmin− 1), whereas the p110δD910A
OT2 T cells did not significantly reduce their velocity
(7.3± 0.19 μmmin− 1). The reduced ability to form stable conjugate
of the p110δD910A OT2 T cells was further indicated by their failure to
increase their arrest coefficients in lymph node slices containing
OVA323-339 peptide (Figure 7b). The median interaction times between
T cells and antigen-bearing DCs in lymph node sections were also
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reduced when p110δD910A where added to the slices (Figure 7c). These
data show that PI3Kδ is required for the establishment of sustained
contacts with DCs in response to antigenic challenge in a lymph node.
Future experiments will establish whether p110δD910A cells also fail to
maintain stable interactions in the context of an inflamed lymph node.
DISCUSSION
In the study we have investigated the effect of inhibiting PI3Kδ on the
ability of CD4+ T cells to form productive conjugates with APCs.
To our initial surprise, we found Rac activity to be intact, or even
enhanced, in p110δD910A T cells after stimulation with anti-CD3. This
contrasts to observations in neutrophils where PI3K has been shown
to positively regulate Rac activity via the protein P-Rex1, which
catalyses the exchange of GDP for GTP on Rac using its GEF
domain.37 However, in subsequent studies, no effect of P-Rex1
deficiency on lymphocyte function was found38 (our unpublished
data). Vav1 is a key regulator of Rac activity in T cells and its capacity
to regulate Rac is dependent on the ability of the Vav-PH domain to
bind PtdIns(4,5)P2 or PIP3.
39 However, as the Vav1 PH domain does
not discriminate effectively between PIP3 and its much more abundant
precursor PtdIns(4,5)P2, it is unlikely that Vav1 is acutely regulated by
PI3Ks. The Rac GEF Dock2 has also been considered to bridge PI3K
signalling to Rac activation. Rac activity is reduced in Dock2− /−
T cells stimulated via the TCR or through chemokines.40–42 During
the activation of CD8+ T cells, actin is cleared from the immune
synapse to facilitate the delivery of cytotoxic granules.41,43 Le Floc’h
and colleagues noted reduced cell spreading and depletion of actin at
the centre of the immune synapse in CD8+ T cells, lacking Dock2 or
that had been inhibited with IC87114.41 Our data are consistent
with this study with regards to cell spreading and impaired actin
reorganisation, but we cannot conclude that this is simply a
consequence of impaired Rac activation. Inactivation of Rac is
mediated by GAP, which stimulates the intrinsic hydrolysis activity
of small GTPases. ArhGAP15 is regulated in a PIP3-dependent manner
and ArhGAP15− /− neutrophils and macrophages show enhanced
Rac activity, which is antagonised by PI3K signalling.44,45 Although
TCR-dependent Rac activity in ArhGAP15− /− T cells is unperturbed
(Garçon F, Costa C, Hirsch E, Okkenhaug K, manuscript in
preparation), these results indicate that Rho-family GAPs as well as
Rho-family GEFs need to be taken into account when considering the
effect of PI3K inhibition on Rac activity in different cell types and
downstream of distinct receptors. Indeed, during phagocytosis, the
activation of up to three different PI3K-dependent Rac-GAPs is
required for actin clearance in a manner reminiscent of that observed
during CTL activation by antigen.46 We propose that impaired actin
reorganisation in p110δD910A CD4+ T cells is a consequence of altered
dynamics in the cycling between the GTP- and GDP-bound states of
Rac, which can be affected both by PIP3-dependent GEFs and GAPs.
Rap1 activation was reduced in p110δD910A T cells stimulated with
anti-CD3, and binding of ICAM-1 to LFA-1 was also impaired
suggesting that PI3Kδ could regulate LFA-1 activation through
Rap1. The capacity of LFA-1 to interact with its ligand ICAM-1 is
regulated by two processes: conformational change, leading to higher
affinity binding, and clustering, leading to increased avidity.20
Although activated Rap1 has been reported to regulate both the
avidity and the affinity of LFA-1, a constitutively active mutant of
Rap1 preferentially increased LFA-1 avidity in primary T cells.26,47 Our
results suggest that PI3Kδ regulates the affinity rather than the avidity
of LFA-1, as PI3Kδ inhibition suppressed binding of LFA-1 on T cells
to a soluble ligand without affecting capping of LFA-1 on the T cells. If
the main effect of activated Rap1 is to increase LFA-1 clustering, then
this would explain the failure of a constitutively active form of Rap1
(Rap1V12) to rescue the binding to ICAM-1 by LFA-1 expressed by
p110δD910A T cells. This may also explain why in a previous study we
found that p110δD910A T cells bound normally to ICAM-1 plate-based
adhesion assay.10 The plate-based adhesion assay used in that study
cannot discriminate between affinity- and avidity-mediated changes in
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Figure 7 PI3Kδ is important for T-DC interactions in lymph node slices.
CD4+ T-cell blasts labelled with CMFDA and RFP+ DCs were added to
congenic lymph node slice in the presence or absence of OVA323-339
peptide. Mean velocity (a) and arrest coefficient (b) of WT and p110δD910A
OT2 cells in presence or absence of peptide. Dashed boxed in (b) indicate
the frequency of WT and p110δD910A OT2 cells with an arrest coefficient
40.7 (arrested). (c) Contact times between OT2 CD4+ T cells and DCs.
(a–c) Data are representative of at least two independent experiments.
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adhesiveness. The present study shows that although p110δD910A
T cells were able to cap LFA-1 at the surface and bind plate-bound
ICAM-1, they failed to spread and had a very small surface of contact.
Contrary to our initial hypothesis, the reduction of Rap1 activity we
observed when PI3Kδ was inhibited is not in itself sufficient to explain
the reduced binding of LFA-1 to ICAM-1. In addition to regulating
integrin affinity, Rap1 is also required for cell spreading and actin
dynamics.48 Rap1 does so by promoting the dephosphorylation and
activation of the actin-severing protein cofilin. Cofilin phosphorylation
is also increased via Rac upon TCR/CD28 engagement.27 Our data
show that PI3Kδ inhibition suppressed cofilin dephosphorylation and
dynamic actin reorganisation required for cell shape modification
and productive interactions with APCs, which may be another
consequence of reduced Rap1 activity. How the reduced Rap1
activation and increased Rac1 activity in p110δD910A T cells is
integrated to regulate cytoskeletal rearrangements and integrin
activation still remains to be fully elucidated, however.
Interestingly, Rap1 activity was also reduced when Akt was
inhibited. Inhibition of Akt also led to a small decreased binding to
ICAM-1 but not as strong as that observed in p110δD910A T cells or
T cells treated with the PI3Kδ inhibitor IC87114. These results
implicate Akt in the regulation of integrins, but also suggest that
PI3K effectors other than Akt mediate PI3K-dependent integrin
activation. Which other PIP3-binding proteins could contribute to
Rap1 activation and increased LFA-1 affinity? SKAP1 is composed of a
unique NH2-terminal region followed by a PH and a SH3 domain.
49,50
Upon TCR engagement, SKAP1 is recruited to an ADAP-SLP-76
complex via the interaction of its SH3 domain with a proline-rich
region in ADAP and then interacts with RapL and allows its
recruitment to Rap1 and LFA-1.50 Like p110δD910A mice, SKAP1-
deficient mice are impaired in forming T-cell–APC conjugates in vitro
and in vivo.50,51 A mutation R131M in the PH domain, which is
predicted to uncouple SKAP1 from regulation by PIP3 inhibits the
ability of SKAP1 to enhance LFA-1 activation in a cell line.49,52
Kindlin-3, a key LFA-1 co-activator deleted in leukocyte-adhesion
deficiency-III, also possesses a PIP3-specific PH domain in its FERM
domain F2.53 Kindlin-3 is required for induction of the high-affinity
conformation of LFA-1.54 Moreover, the PH domain of Kindlin-3 is
essential for LFA-1-mediated regulation of lymphocyte adhesion and
migration.55 The intermediate affinity conformation of LFA-1 requires
Talin-1, whereas further conformational changes associated with the
high-affinity state are Kindlin-3 dependent.54 Further work will
help delineate how different PIP3-binding proteins co-ordinate the
regulation of LFA-1 affinity and avidity. These studies may be
facilitated using human T cells as antibodies that distinguish between
low-, medium- and high-affinity forms of human LFA-1 are available.
T-cell activation within the spleen or lymph nodes occurs through
multiple stages over a period of up to 30 h, starting with transient
contacts that allow T cells to scan a large number of APCs and then
proceeding to longer-lasting interactions once an APC-bearing cognate
peptide antigen is encountered.33,56,57 Although shorter interactions
can stimulate T-cell proliferation and cytokine production, sustained
dynamic interactions are thought to be required to initiate differentia-
tion programs and for immunological memory.21,22 Consistent with
previous results,36,58 we found that PI3K inhibition did not affect the
basal motility of T cells moving through lymph nodes in absence of
antigen. However, when presented with antigen, p110δD910A T cells
failed to establish stable conjugates with APCs. This defect is likely to
be a contributing factor to the impaired T-cell responses to antigen in
p110δD910A mice.
METHODS
Mice
OT2 and p110δD910A mice on the C57BL/6 genetic background were described
previously (and references therein).12 Mice expressing tdRFP from the Rosa26
locus were obtained from the European Mouse Mutant Archive.59 Mice were
maintained under specific pathogen-free conditions. All protocols involving live
animals were approved by the UK Home Office and the Babraham Institute
Animal Welfare, Experimental Ethical Review Committee and in accordance
with the Animals (Scientific Procedures) Act 1986.
Reagents
OVA323-339 peptide was synthesised by Southampton Polypeptides. IC87114
was synthesised as described previously.14,60 Akt inhibitor VIII (Akti ½) was
purchased from Merck Millipore (Billerica, MA, USA) and used at 2 μM.
ZSTK-474 was purchased from Selleck (Houston, TX, USA) and used at
100 nM. The different glutathione S-transferase (GST) fusion proteins
containing the CRIB (Cdc42/Rac1 interactive binding) domain of
PAK (GST-PAK-CRIB), the Rho-binding domain (RBD) of Rhotekin
(GST-Rhotekin-RBD) or the Ras-binding domain (RBD) of RalGDS
(GST-Ral-RBD) were a gift from Heidi Welch (Babraham Institute).
HA-Rap1V12 was cloned into MIGR-1-IRES-GFP using the Gateway cloning
technology from Life technologies (Grand Island, NY, USA). The human p110δ
retroviral construct was described previously.61 The recombinant murine
MIP-3β (CCL19) was obtained from Peprotech (London, UK).
Antibodies
The following antibodies were used in this study: anti-Rac1 (clone 23A8)
from Millipore, anti-Cdc42, anti-RhoA and anti-Ezrin from Santa Cruz
Biotechnology (Santa Cruz, CA, USA), anti-Rap1 antibody from Epitomics
(Burlingame, CA, USA) and Cell Signaling Technology (Boston, MA, USA),
anti-cofilin, anti-phospho-cofilin (Ser3) and anti-phospho-ERM from Cell
Signaling Technology, anti- mouse CD11a (clone M17/4) and anti-CD4 from
eBioscience (San Diego, CA, USA).
Cell purification and transfections
Naive T cells were purified from lymph nodes by magnetic sorting (Miltenyi
Biotec, Auburn, CA, USA). For total CD4+ T-cell purification, non-CD4+
T cells were labelled with fluorescein isothiocyanate-conjugated anti-CD8, anti-
CD69, anti-CD25, anti-B220, anti-CD49b and anti-major histocompatibility
complex class II, followed by negative selection with anti-fluorescein
isothiocyanate magnetic cell sorting beads (Miltenyi Biotec). More than 95%
of the cells isolated were CD4+.
OT2 T-cell blasts were obtained by stimulation of cells from spleens with
1 μM OVA323-339 peptide for 6 days. CD4+ T cells were purified by magnetic
sorting and cultured with 20 ng ml− 1 of interleukin-2. Before any experiments,
cells were washed to remove interleukin-2 and rested for 2 h. For the actin-GFP
analysis, OT2 T-cell blasts were transfected with 6 μg of pcDNA3-actin-GFP
with the Amaxa Nucleofactor technology (Lonza, Basel, Switzerland) according
to the manufacturer’s instructions.
APCs used in this study were T-cell depleted splenocytes isolated with
anti-mouse Thy1.2 (Sigma-Aldrich, St Louis, MO, USA) and rabbit complement
(Cedarlane, Burlington, ON, USA), followed by purification of viable cells using
Lympholyte-M (Cedarlane). The APCs were activated by overnight exposure to
lipopolysaccharide with or without the OVA323-339 peptide.
DCs were purified from collagenase-digested spleen and isolated by magnetic
sorting using CD11c microbeads (Miltenyi Biotec).
GST pull-downs and western blot analysis
Purified CD4+ T cells (2–5× 106) were incubated with anti-CD3 (2C11 at
10 μg ml− 1) alone or in combination with anti-CD28 (37.51 at 10 μg ml− 1) on
ice for 30 min. Cells were washed once in ice-cold RPMI, incubated 2 min at
37 °C and then stimulated with goat anti-hamster immunoglobulin G (Jackson
ImmunoResearch Laboratory, West Grove, PA, USA) for the indicated times.
Cells were lysed in ice-cold lysis buffer (50 mM 4-(2-hydroxyethyl)-1-piper-
azineethanesulfonic acid, 150 mM NaCl, 10 mM NaF, 10 mM iodoacetamide,
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1% NP-40, 1 mM phenylmethylsulfonyl fluoride and protease inhibitors) and
mechanically sheared using a needle and syringe. Proteins were resolved on
NuPage 4–12% BisTris gels (Invitrogen, Life Technologies Ltd., Paisley, UK),
transferred to polyvinylidene difluoride membranes and probed with the
indicated antibodies.
For small G proteins analysis, lysates were incubated with the appropriate
GST fusion protein (GST-PAK-CRIB, GST-Rhotekin-RBD and GST-Ral-RBD),
coupled to glutathione-Sepharose beads for 2 h at 4 °C. Pull-downs were
washed three times in ice-cold lysis buffer, and resolved as described above.
Imaging of T-cell conjugates and migration on slides
CD4+ T-cell–APC conjugate formation and imaging were performed as
described previously.12
To examine T-cell motility in vitro, GFP-positive CD4+ T cells were added to
the APCs already adhered to a coverslip and images were taken every 15 s. For
velocity measurement, GFP+ cells were tracked to draw a path using the Imaris
software.
To measure the number of conjugates formed, for each coverslip three
different fields of view randomly chosen were imaged with a × 40 objective. In
order to differentiate the T cells we used a PE-anti-CD3ε (2C11) antibody.
T cells forming a close contact with an APC were considered positive for
conjugate formation.
Actin redistribution at the T-cell-APC interface was defined as the ratio of the
intensity of fluorescence at the contact and the intensity of fluorescence of the rest
of the membrane. Background noise was determined as the average signal in an
area without cell and was subtracted from the overall output. Images of conjugates
were obtained on an Olympus FV-1000 system consisting of an Olympus IX81
microscope fitted with an Olympus Plan super Apochromat ×60/1.4 numerical
aperture oil objective (Olympus Europa GmbH, Hamburg, Germany).
ICAM-1 complexes-based adhesion assays
To generate ICAM-1-Fc-F(ab’)2 complexes (scICAM-1) APC- or
phycoerythrin-labelled anti-human Fcγ-specific immunoglobulin G F(ab’)2
fragments (Jackson ImmunoResearch) and recombinant mouse ICAM-1 Fc
(R&D Systems, Minneapolis, MN, USA) were incubated at 4 °C for 30 min in
phosphate-buffered saline (PBS) as described previously.30
Primary CD4+ T cells were incubated for 30 min at 4 °C with 1 μg ml− 1 of
anti-CD3ε (2C11). The cells were then activated by cross-linking with anti-
Armenian Hamster immunoglobulin G at 37 °C in presence of scICAM-1. For
the control experiments, the cells were activated with PMA (51 ng ml− 1) or
Mg2+/EGTA (10 mM/1 mM) or CCL19 (250 ng ml− 1). After the indicated
time the reaction was stopped by fixation with 4% paraformaldehyde for 5 min.
The samples were then washed in PBS+10% fetal calf serum, stained with
phycoerythrin- or APC-labelled anti-CD4 and analysed on a fluorescence-
activated cell sorting-Calibur.
For LFA-1 clustering experiments, T cells were incubated with anti-CD3ε for
30 min on ice. Cells were then washed and cross-linked with anti-Armenian
Hamster immunoglobulin G for 30 min at 37 °C. Cells were fixed with 4%
paraformaldehyde, washed and blocked with 10% fetal calf serum-PBS for
30 min. Cells were then stained for anti-CD11a and imaged on a Olympus
FV-1000 microscope fitted with a Olympus Plan super Apochromat × 60/1.4
numerical aperture oil objective.
Retroviral transduction of T-cell blasts
WT and p110δD910A T-cell blasts were obtained by stimulating whole-lymph
node cell suspension with anti-CD3 mAb (2C11 clone at 1 μg ml− 1) and
recombinant human interleukin-2 (20 ng ml− 1) for 2 days. 24 h before the
transduction, six-well non-tissue culture plates were coated with Retronectin
(Takara Bio Inc., Otsu, Japan) at 50 μg ml− 1 in PBS overnight at 4 °C. After
removing the retronectin, the plates were blocked in PBS+0.5% bovine serum
albumin at room temperature for 30 min. The virus-containing supernatant
from Plat-E packaging cells was added to the plate and centrifuged at 2000 g at
32 °C for 90 min. After discarding the supernatant the same procedure was
repeated with a second aliquot. T-cell blasts (2× 106) in culture media with
interleukin-2 were added to the virus-coated plate and centrifuged at 500 g for
30 min. Cells were used 2 days after the transduction.
Lymph node slice imaging
Lymph nodes preparation was mostly done as described previously.36 For
antigen-dependent T-cell motility, slices were loaded with 10 μM of OVA323-339
peptide and incubated for 1 h at 37 °C. For T cell-DC interactions, 0.2 × 106
RFP+ DCs loaded with 10 μM of OVA323-339 peptide were incubated on the slice
for 30 min prior to the addition of the T cells. 0.2 × 106 OT2 CD4+ T cells,
labelled with 1 μM of the cell tracker CMFDA, were then incubated on the slice
for 30–60 min in the incubator. The preparation was then thoroughly washed
and placed in the perfusion chamber on the microscope. Image were acquired
every 20 s for 10–30 min with a × 10 objective on an Olympus CellR system or
with a × 20 water immersion objective on a Zeiss 7MP two-photon system. Raw
images were treated with Imaris software (Bitplane, Zürich, Switzerland).
Imaris Spots module was used to track objects and calculate cell coordinates
over time. The resulting tracks were manually checked. Contact times between
T cells and DCs, defined as a close association persisting for 41 min, were
scored manually by counting the number of frames they persisted for.
Quantification of the normalised compactness
The normalised compactness (Cn) or polarisation index, a measure of the
shape of the cell, was determined as previously described.62 The contours of the
T cell were determined using the differential interference contrast (DIC) or
interference reflection microscopy (IRM) image. From the contours we
estimated the shape of the cell according to the formula Cn= 1− (4πA/P2)
where A is the area and P the perimeter. A value of 0 represents a perfect circle
(non-polarised cell) and a value of 1 a straight line (fully polarised cell).
Data and statistical analysis
Images were assembled and analysed with Imaris Bitplane and the Volocity
software package (Improvision, Waltham, MA, USA). All statistical analyses
were performed using Prism 6.0 software (GraphPad Software, San Diego,
CA, USA).
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